Single-Cell Genomics Market 2026-2034 | Size, Share & Trends
Coverage: Single-Cell Genomics Market covers analysis By Product (Consumables, Instruments, Software & Service); Sequencing Technology (Next-Generation Sequencing (NGS), Nanopore Sequencing); Application (Oncology, Immunology, Neurology, Infectious Diseases, Stem Cell Research); End User (Academic & Research Institutes, Pharmaceutical & Biotechnology Companies, Clinical & Translational Research Centers, CROs); and Geography
- Report Date : Feb 2026
- Report Code : TIPRE00042214
- Category : Life Sciences
- Status : Upcoming
- Available Report Formats :
- No. of Pages : 150
The single-cell genomics market size is expected to reach US$ 5.22 billion by 2034 from US$ 1.96 billion in 2025. The market is anticipated to register a CAGR of 11.50% during 2026–2034.
Single-Cell Genomics Market AnalysisThe Single-Cell Genomics market forecast indicates significant growth, with a growing understanding of cellular heterogeneity in the development of diseases, especially cancer. Major factors driving the growth of this market include cost reductions and improved accessibility achieved by advancements in high-throughput sequencing technologies and microfluidic devices. Intense focus on personalized medicine and integration of sophisticated bioinformatics tools accelerates these trends.
Single-Cell Genomics Market OverviewSingle-Cell Genomics is the study of the genome and transcriptome of individual cells, providing unprecedented resolution into complex biological systems that bulk sequencing methods cannot achieve. Systems and technologies make the analysis of genetic variation, gene expression, and regulatory elements easier on a single-cell basis. With the precise profiling of rare cell populations such as CTCs enabled, Single-Cell Genomics forms the very basis of oncology, immunology, and developmental biology research.
Strategic Insights
Single-Cell Genomics Market Drivers and OpportunitiesMarket Drivers:
- Growing Instances of Cancer and Other Chronic Diseases: The increasing global incidence of cancer and autoimmune disorders is a prime driver, as single-cell analysis becomes necessary for unraveling cellular mechanisms of these conditions toward the path of correct diagnosis and treatment.
- Escalating Demand for Personalized Medicine and Targeted Therapies: The global trend towards precision medicine means that highly specific cellular and molecular information is in demand, hence directly driving the demand for high-resolution single-cell technologies.
- Advancements in High-Throughput and Microfluidic Technologies: Ongoing technological refinements in sequencing and microfluidic platforms are leading to higher throughput, lower costs, and greater accessibility, making single-cell analysis a more viable option for research and clinical settings.
Market Opportunities:
- Integration with Multi-Omics and Spatial Transcriptomics: The market is witnessing a major trend in integrating genomics with single-cell proteomics and spatial transcriptomics, creating new research use cases that offer a more complete picture of cellular function and location within tissues.
- Drug Discovery and Development: Single-cell sequencing is increasingly being employed by pharmaceutical and biotechnology companies for new drug target identification, biomarker discovery, and patient stratification toward clinical trials, hence hastening the creation of precision therapies.
- Adoption of AI-Driven Data Analysis and Cloud Computing: The proliferation of vast single-cell datasets is driving the demand for AI-powered bioinformatics tools and cloud computing platforms to perform complex analysis and interpretation efficiently.
Single-Cell Genomics market share is analyzed across various segments to provide a clearer understanding of its structure, growth potential, and emerging trends. Below is the standard segmentation approach used in most industry reports:
By Product:
- Consumables: Accounted for the highest revenue in 2024, driven by recurring demand for reagents and kits.
- Instruments: Expected to grow at a strong CAGR due to spatial-omics upgrades and modular add-ons.
- Software & Services: Subscription-based analytics and cloud platforms are gaining traction.
By Sequencing Technology:
- Next-Generation Sequencing (NGS): Held a larger market share in 2024.
- Nanopore Sequencing: Poised for the highest growth at a robust CAGR.
By Application:
- Oncology: Largest segment with the highest share in 2024.
- Immunology: Fastest-growing at strongest CAGR.
- Neurology, Infectious Diseases, Stem Cell Research: Emerging applications.
By End User:
- Academic & Research Institutes: Dominated with a higher share in 2024.
- Pharmaceutical & Biotechnology Companies: Expected to grow at highest CAGR.
- Clinical & Translational Research Centers, CROs: Increasing adoption.
By Geography:
- North America
- Europe
- Asia Pacific
- South & Central America
- Middle East & Africa
Market Report Scope
Single-Cell Genomics Market Share Analysis by GeographyAsia Pacific is expected to grow fastest in the coming years. Emerging markets in South & Central America and the Middle East & Africa also have many untapped opportunities for single-cell genomics providers to expand.
The market shows a different growth trajectory in each region due to factors such as advanced life science research infrastructure, R&D funding, regulatory environment, and digital health adoption. Below is a summary of market share and trends by region:
North America
- Market Share: Holds the largest market share in 2023.
- Key Drivers:
- Advanced life science research infrastructure and high R&D investments.
- High incidence of chronic diseases (especially cancer), driving demand for precision oncology tools.
- Presence of numerous key market players and frequent new product launches.
- Trends: Continuous integration of single-cell technologies with Next-Generation Sequencing (NGS) and multi-omics platforms to advance personalized medicine and clinical applications.
Europe
- Market Share: Holds a significant share, driven by strong government research support.
- Key Drivers:
- Government-backed initiatives supporting genomics research and personalized medicine.
- Robust academic and institutional funding for life science R&D.
- Strict regulatory data governance (e.g., GDPR-compliant research) ensuring high data quality standards.
- Trends: Increasing use of single-cell sequencing in national health initiatives and growing adoption of AI-driven tools for complex single-cell data analysis.
Asia Pacific
- Market Share: Fastest-growing region
- Key Drivers:
- Rising government funding for genomics and health IT projects in countries like China and India.
- Expanding biopharma R&D and manufacturing capabilities.
- Increasing investments in healthcare infrastructure and research institutions.
- Trends: Rapid technological adoption and high demand for cost-effective single-cell solutions, driven by a rising patient burden of chronic and genetic diseases.
South & Central America
- Market Share: Emerging market with strong growth potential.
- Key Drivers:
- Rising healthcare investments and expansion of private research centers.
- Growing need for medical practice automation and administrative efficiency.
- Trends: Increasing adoption of cloud-based solutions to overcome infrastructure limitations and growth in public-private health partnerships promoting advanced diagnostics.
Middle East & Africa
- Market Share: Developing market with strong growth potential.
- Key Drivers:
- National e-health strategies and government focus on healthcare infrastructure expansion.
- Need for advanced diagnostic and research tools to address regional health challenges.
- Trends: Implementation of sophisticated genomics technology, often supported by major international collaborations and public health funding dedicated to medical practice automation.
High Market Density and Competition The global single-cell sequencing market is consolidated and dominated by a few key players. Competition is intensifying as established life science giants and specialized genomics firms strive for market leadership.
This competitive environment pushes vendors to differentiate through:
- Developing next-generation platforms that offer ultra-rapid, high-throughput sequencing, such as the sequencing by expansion (SBX) technology.
- Seamlessly integrating microfluidics, sequencing platforms, and proprietary software for a complete, simplified workflow.
- Strategic collaborations to streamline workflows, such as the partnership between Oxford Nanopore Technologies and 10x Genomics.
- Continuous product innovation, focusing on single-cell multi-omics and high-throughput solutions for complex applications like oncology.
- Focus on single-cell multi-omics (simultaneous analysis of DNA, RNA, and protein) to unlock complex biological insights in disease research.
- Develop cost-effective, decentralized platforms to accelerate adoption in smaller research labs and clinical settings worldwide.
- 10x Genomics, Inc. United States
- Illumina, Inc. United States
- BD (Becton, Dickinson and Company) United States
- Thermo Fisher Scientific, Inc. United States
- QIAGEN N.V. Netherlands / Germany
- Bio-Rad Laboratories, Inc. United States
- Merck KGaA Germany
- Standard BioTools, Inc. (Fluidigm Sciences, Inc.) United States
- Roche Holding AG Switzerland
- Oxford Nanopore Technologies plc. United Kingdom
- Pacific Biosciences of California, Inc. United States
- Takara Bio Inc. Japan
Disclaimer: The companies listed above are not ranked in any particular order.
Single-Cell Genomics Market News and Recent Developments- 10x Genomics launched GEM-X Single Cell Gene Expression v4 and Immune Profiling v3 assays : 10x Genomics introduced its next-generation GEM-X assays, offering 2x more genes detected, improved cell recovery, and reduced cost per cell. These innovations support high-throughput CRISPR screens and spatial transcriptomics, enhancing cancer drug discovery and immune profiling.
- Illumina unveiled BioInsight and PromoterAI for multiomic data analysis and rare disease diagnosis : Illumina launched BioInsight, a new business unit focused on AI-powered multiomic analytics, and PromoterAI, an algorithm designed to accelerate rare disease diagnosis. The company also introduced 5-base sequencing and expanded its spatial transcriptomics capabilities through the acquisition of SomaLogic.
The "Single-Cell Genomics Market Size and Forecast (2025–2031)" report provides a detailed analysis of the market covering the following areas:
- Single-Cell Genomics Market size and forecast at global, regional, and country levels for all the key market segments covered under the scope
- Single-Cell Genomics Market trends, as well as market dynamics such as drivers, restraints, and key opportunities
- Detailed PEST and SWOT analysis
- Single-Cell Genomics Market analysis covering key market trends, global and regional framework, major players, regulations, and recent market developments
- Industry landscape and competition analysis covering market concentration, heat map analysis, prominent players, and recent developments in the Single-Cell Genomics Market
- Detailed company profiles
Have a question?
Mrinal
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
Oncology leads the market, followed by immunology, neurology, infectious diseases, and stem cell research.
Rising cancer cases, growing demand for personalized medicine, and advances in sequencing and microfluidic technologies are driving market growth.
Asia Pacific will grow the fastest due to strong R&D investments, government support, and rising healthcare infrastructure.
Major players include 10x Genomics, Illumina, Thermo Fisher Scientific, BD, QIAGEN, Bio-Rad, Merck, Roche, and Oxford Nanopore Technologies.
Integration of multi-omics, AI-driven data analysis, and cloud computing will define future growth, making single-cell technologies more accessible and precise.
Yes! We provide a free sample of the report, which includes Report Scope (Table of Contents), report structure, and selected insights to help you assess the value of the full report. Please click on the "Download Sample" button or contact us to receive your copy.
Absolutely - analyst assistance is part of the package. You can connect with our analyst post-purchase to clarify report insights, methodology or discuss how the findings apply to your business needs.
Once your order is successfully placed, you will receive a confirmation email along with your invoice.
• For published reports: You'll receive access to the report within 4-6 working hours via a secured email sent to your email.
• For upcoming reports: Your order will be recorded as a pre-booking. Our team will share the estimated release date and keep you informed of any updates. As soon as the report is published, it will be delivered to your registered email.
We offer customization options to align the report with your specific objectives. Whether you need deeper insights into a particular region, industry segment, competitor analysis, or data cut, our research team can tailor the report accordingly. Please share your requirements with us, and we'll be happy to provide a customized proposal or scope.
The report is available in either PDF format or as an Excel dataset, depending on the license you choose.
The PDF version provides the full analysis and visuals in a ready-to-read format. The Excel dataset includes all underlying data tables for easy manipulation and further analysis.
Please review the license options at checkout or contact us to confirm which formats are included with your purchase.
Our payment process is fully secure and PCI-DSS compliant.
We use trusted and encrypted payment gateways to ensure that all transactions are protected with industry-standard SSL encryption. Your payment details are never stored on our servers and are handled securely by certified third-party processors.
You can make your purchase with confidence, knowing your personal and financial information is safe with us.
Yes, we do offer special pricing for bulk purchases.
If you're interested in purchasing multiple reports, we're happy to provide a customized bundle offer or volume-based discount tailored to your needs. Please contact our sales team with the list of reports you're considering, and we'll share a personalized quote.
Yes, absolutely.
Our team is available to help you make an informed decision. Whether you have questions about the report's scope, methodology, customization options, or which license suits you best, we're here to assist. Please reach out to us at sales@theinsightpartners.com, and one of our representatives will get in touch promptly.
Yes, a billing invoice will be automatically generated and sent to your registered email upon successful completion of your purchase.
If you need the invoice in a specific format or require additional details (such as company name, GST, or VAT information), feel free to contact us, and we'll be happy to assist.
Yes, certainly.
If you encounter any difficulties accessing or receiving your report, our support team is ready to assist you. Simply reach out to us via email or live chat with your order information, and we'll ensure the issue is resolved quickly so you can access your report without interruption.
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Get Free Sample For